Global and United States Irritable Bowel Syndrome (IBS) Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 10-Sep-2021
No. of pages: 97
Inquire Before Buying

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

North America is the largest region of Irritable Bowel Syndrome (IBS), with a market share about 75%. Allergan, Valeant Pharmaceuticals, Takeda, Sucampo Pharmaceuticals and McNeil Consumer Healthcare are the top 5 manufacturers of industry, and they had about 80% combined market share.

Market Analysis and Insights: Global Irritable Bowel Syndrome (IBS) Market

The global Irritable Bowel Syndrome (IBS) market size is projected to reach US$ 10960 million by 2027, from US$ 4130.9 million in 2020, at a CAGR of 15.0% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Irritable Bowel Syndrome (IBS) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Irritable Bowel Syndrome (IBS) market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Irritable Bowel Syndrome (IBS) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Irritable Bowel Syndrome (IBS) market.

Global Irritable Bowel Syndrome (IBS) Scope and Market Size

Irritable Bowel Syndrome (IBS) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Irritable Bowel Syndrome (IBS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- IBS-D Drug

- IBS-C Drug

- Others

Segment by Application

- Women

- Men

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Bausch Health

- Allergan

- Takeda

- Sucampo Pharmaceuticals (Mallinckrodt)

- Sebela Pharmaceuticals Inc

- Astellas Pharmaceuticals

Global and United States Irritable Bowel Syndrome (IBS) Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 IBS-D Drug
1.2.3 IBS-C Drug
1.2.4 Others
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Women
1.3.3 Men
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome (IBS) Market Perspective (2016-2027)
2.2 Irritable Bowel Syndrome (IBS) Growth Trends by Regions
2.2.1 Irritable Bowel Syndrome (IBS) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Irritable Bowel Syndrome (IBS) Historic Market Share by Regions (2016-2021)
2.2.3 Irritable Bowel Syndrome (IBS) Forecasted Market Size by Regions (2022-2027)
2.3 Irritable Bowel Syndrome (IBS) Industry Dynamic
2.3.1 Irritable Bowel Syndrome (IBS) Market Trends
2.3.2 Irritable Bowel Syndrome (IBS) Market Drivers
2.3.3 Irritable Bowel Syndrome (IBS) Market Challenges
2.3.4 Irritable Bowel Syndrome (IBS) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue
3.1.1 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2016-2021)
3.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Players (2016-2021)
3.2 Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Irritable Bowel Syndrome (IBS) Revenue
3.4 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome (IBS) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome (IBS) Revenue in 2020
3.5 Irritable Bowel Syndrome (IBS) Key Players Head office and Area Served
3.6 Key Players Irritable Bowel Syndrome (IBS) Product Solution and Service
3.7 Date of Enter into Irritable Bowel Syndrome (IBS) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Irritable Bowel Syndrome (IBS) Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Type (2016-2021)
4.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2022-2027)
5 Irritable Bowel Syndrome (IBS) Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome (IBS) Historic Market Size by Application (2016-2021)
5.2 Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
6.2 North America Irritable Bowel Syndrome (IBS) Market Size by Type
6.2.1 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
6.2.2 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
6.2.3 North America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
6.3 North America Irritable Bowel Syndrome (IBS) Market Size by Application
6.3.1 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
6.3.2 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
6.3.3 North America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
6.4 North America Irritable Bowel Syndrome (IBS) Market Size by Country
6.4.1 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
6.4.2 North America Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
7.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type
7.2.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
7.2.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
7.2.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
7.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application
7.3.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
7.3.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
7.3.3 Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
7.4 Europe Irritable Bowel Syndrome (IBS) Market Size by Country
7.4.1 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
7.4.2 Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
8.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type
8.2.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
8.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application
8.3.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
8.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region
8.4.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
9.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type
9.2.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
9.2.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
9.2.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
9.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application
9.3.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
9.3.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
9.3.3 Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
9.4 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country
9.4.1 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
9.4.2 Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size (2016-2027)
10.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type
10.2.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2027)
10.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application
10.3.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2027)
10.4 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country
10.4.1 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Introduction
11.1.4 Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.1.5 Bausch Health Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Irritable Bowel Syndrome (IBS) Introduction
11.2.4 Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.2.5 Allergan Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Irritable Bowel Syndrome (IBS) Introduction
11.3.4 Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.3.5 Takeda Recent Development
11.4 Sucampo Pharmaceuticals (Mallinckrodt)
11.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Company Details
11.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
11.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Introduction
11.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
11.5 Sebela Pharmaceuticals Inc
11.5.1 Sebela Pharmaceuticals Inc Company Details
11.5.2 Sebela Pharmaceuticals Inc Business Overview
11.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Introduction
11.5.4 Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.5.5 Sebela Pharmaceuticals Inc Recent Development
11.6 Astellas Pharmaceuticals
11.6.1 Astellas Pharmaceuticals Company Details
11.6.2 Astellas Pharmaceuticals Business Overview
11.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Introduction
11.6.4 Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021)
11.6.5 Astellas Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Irritable Bowel Syndrome (IBS) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of IBS-D Drug
Table 3. Key Players of IBS-C Drug
Table 4. Key Players of Others
Table 5. Global Irritable Bowel Syndrome (IBS) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Irritable Bowel Syndrome (IBS) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Irritable Bowel Syndrome (IBS) Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Irritable Bowel Syndrome (IBS) Market Share by Regions (2016-2021)
Table 9. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Irritable Bowel Syndrome (IBS) Market Share by Regions (2022-2027)
Table 11. Irritable Bowel Syndrome (IBS) Market Trends
Table 12. Irritable Bowel Syndrome (IBS) Market Drivers
Table 13. Irritable Bowel Syndrome (IBS) Market Challenges
Table 14. Irritable Bowel Syndrome (IBS) Market Restraints
Table 15. Global Irritable Bowel Syndrome (IBS) Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Irritable Bowel Syndrome (IBS) Market Share by Players (2016-2021)
Table 17. Global Top Irritable Bowel Syndrome (IBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2020)
Table 18. Ranking of Global Top Irritable Bowel Syndrome (IBS) Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Irritable Bowel Syndrome (IBS) Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Irritable Bowel Syndrome (IBS) Product Solution and Service
Table 22. Date of Enter into Irritable Bowel Syndrome (IBS) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2021)
Table 26. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Irritable Bowel Syndrome (IBS) Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2016-2021)
Table 30. Global Irritable Bowel Syndrome (IBS) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bausch Health Company Details
Table 63. Bausch Health Business Overview
Table 64. Bausch Health Irritable Bowel Syndrome (IBS) Product
Table 65. Bausch Health Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021) & (US$ Million)
Table 66. Bausch Health Recent Development
Table 67. Allergan Company Details
Table 68. Allergan Business Overview
Table 69. Allergan Irritable Bowel Syndrome (IBS) Product
Table 70. Allergan Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021) & (US$ Million)
Table 71. Allergan Recent Development
Table 72. Takeda Company Details
Table 73. Takeda Business Overview
Table 74. Takeda Irritable Bowel Syndrome (IBS) Product
Table 75. Takeda Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021) & (US$ Million)
Table 76. Takeda Recent Development
Table 77. Sucampo Pharmaceuticals (Mallinckrodt) Company Details
Table 78. Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
Table 79. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product
Table 80. Sucampo Pharmaceuticals (Mallinckrodt) Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021) & (US$ Million)
Table 81. Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
Table 82. Sebela Pharmaceuticals Inc Company Details
Table 83. Sebela Pharmaceuticals Inc Business Overview
Table 84. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product
Table 85. Sebela Pharmaceuticals Inc Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021) & (US$ Million)
Table 86. Sebela Pharmaceuticals Inc Recent Development
Table 87. Astellas Pharmaceuticals Company Details
Table 88. Astellas Pharmaceuticals Business Overview
Table 89. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table 90. Astellas Pharmaceuticals Revenue in Irritable Bowel Syndrome (IBS) Business (2016-2021) & (US$ Million)
Table 91. Astellas Pharmaceuticals Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Irritable Bowel Syndrome (IBS) Market Share by Type: 2020 VS 2027
Figure 2. IBS-D Drug Features
Figure 3. IBS-C Drug Features
Figure 4. Others Features
Figure 5. Global Irritable Bowel Syndrome (IBS) Market Share by Application: 2020 VS 2027
Figure 6. Women Case Studies
Figure 7. Men Case Studies
Figure 8. Irritable Bowel Syndrome (IBS) Report Years Considered
Figure 9. Global Irritable Bowel Syndrome (IBS) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Irritable Bowel Syndrome (IBS) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Irritable Bowel Syndrome (IBS) Market Share by Regions: 2020 VS 2027
Figure 12. Global Irritable Bowel Syndrome (IBS) Market Share by Regions (2022-2027)
Figure 13. Global Irritable Bowel Syndrome (IBS) Market Share by Players in 2020
Figure 14. Global Top Irritable Bowel Syndrome (IBS) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome (IBS) Revenue in 2020
Figure 16. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2021)
Figure 17. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2022-2027)
Figure 18. North America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Irritable Bowel Syndrome (IBS) Market Share by Type (2016-2027)
Figure 20. North America Irritable Bowel Syndrome (IBS) Market Share by Application (2016-2027)
Figure 21. North America Irritable Bowel Syndrome (IBS) Market Share by Country (2016-2027)
Figure 22. United States Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Irritable Bowel Syndrome (IBS) Market Share by Type (2016-2027)
Figure 26. Europe Irritable Bowel Syndrome (IBS) Market Share by Application (2016-2027)
Figure 27. Europe Irritable Bowel Syndrome (IBS) Market Share by Country (2016-2027)
Figure 28. Germany Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Irritable Bowel Syndrome (IBS) Market Share by Region (2016-2027)
Figure 38. China Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Irritable Bowel Syndrome (IBS) Market Share by Type (2016-2027)
Figure 46. Latin America Irritable Bowel Syndrome (IBS) Market Share by Application (2016-2027)
Figure 47. Latin America Irritable Bowel Syndrome (IBS) Market Share by Country (2016-2027)
Figure 48. Mexico Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Irritable Bowel Syndrome (IBS) Market Share by Country (2016-2027)
Figure 54. Turkey Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Irritable Bowel Syndrome (IBS) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2016-2021)
Figure 58. Allergan Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2016-2021)
Figure 59. Takeda Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2016-2021)
Figure 60. Sucampo Pharmaceuticals (Mallinckrodt) Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2016-2021)
Figure 61. Sebela Pharmaceuticals Inc Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2016-2021)
Figure 62. Astellas Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome (IBS) Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
  • Global Anti-Peptic Ulcer Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Anti-Peptic Ulcer Drugs market size was valued at US$ 8523.5 million in 2023. With growing demand in downstream market, the Anti-Peptic Ulcer Drugs is forecast to a readjusted size of US$ 21200 million by 2030 with a CAGR of 13.9% during review period. The research report highlights the growth potential of the global Anti-Peptic Ulcer Drugs market. Anti-Peptic Ulcer Drugs are expected to show stable growth in the future marke......
  • Global Lansoprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 102
    The Lansoprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lansoprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88
    According to our LPI (LP Information) latest study, the global Irritable Bowel Syndrome (IBS) market size was valued at US$ 4634.2 million in 2023. With growing demand in downstream market, the Irritable Bowel Syndrome (IBS) is forecast to a readjusted size of US$ 12750 million by 2030 with a CAGR of 15.6% during review period. The research report highlights the growth potential of the global Irritable Bowel Syndrome (IBS) market. Irritable Bowel Syndrome (IBS) are expected to show stabl......
  • Global Esomeprazole Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 89
    The Esomeprazole market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Esomeprazole market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the comp......
  • Global Irritable Bowel Syndrome (IBS) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 126
    Market Overview of Global Irritable Bowel Syndrome (IBS) market: According to our latest research, the global Irritable Bowel Syndrome (IBS) market looks promising in the next 5 years. As of 2022, the global Irritable Bowel Syndrome (IBS) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive anal......
  • Global Diarrhea Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 109
    Market Overview of Global Diarrhea Drug market: According to our latest research, the global Diarrhea Drug market looks promising in the next 5 years. As of 2022, the global Diarrhea Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Diarrhea Drug market, with a sys......
  • Drugs for Traveler's Diarrhea - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 96
    This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with bo......
  • Global Lansoprazole Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 136
    Lansoprazole reduces the amount of acid your stomach makes. It's used for indigestion, heartburn and acid reflux and gastroesophageal-reflux-disease (GORD). Lansoprazole is also taken to prevent and treat stomach ulcers. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their g......
  • Global Pentasa (Ulcerative Colitis) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 113
    Market Overview of Global Pentasa (Ulcerative Colitis) market: According to our latest research, the global Pentasa (Ulcerative Colitis) market looks promising in the next 5 years. As of 2022, the global Pentasa (Ulcerative Colitis) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis o......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs